The Centers for Medicare & Medicaid Services has revised the way Medicare administrative contractors make local coverage determinations for medical technologies, as required by the 21st Century Cures Act to promote transparency. Among other changes, the updated process expands who can participate on the contractor advisory committees that inform LCDs, opens CAC meetings to the public and requires a standardized summary of the clinical evidence supporting an LCD decision. CMS said the changes, published as an update to the Medicare Program Integrity Manual, will clarify and simplify the LCD process so that companies can get therapies and devices to patients more efficiently.

Related News Articles

Headline
The Medicare Payment Advisory Commission March 15 released its March report to Congress, which includes its recent recommendations for hospital and other…
Headline
Responding March 15 to a House Committee on Education and the Workforce request for comments on ways to strengthen the Employee Retirement Income Security Act…
Blog
The Medicare Payment Advisory Commission (MedPAC) today released its annual March Report advising Congress on the Medicare fee-for-service (FFS) payment…
Headline
The Centers for Medicare & Medicaid Services March 7 invited drug makers in the Medicaid Drug Rebate Program that make federally approved gene therapies…
Headline
The House March 6 voted 339-85 to pass a package of six appropriations bills that would fund certain federal agencies through fiscal year 2024 and contains…
Headline
AHA Feb. 26 submitted comments on the Centers for Medicare & Medicaid Services’ proposed rule establishing appeals rights for Medicare beneficiaries…